Survival of patients with small cell carcinoma of the prostate during 1973-2003: A population-based study

BJU International

Volumn 109, Issue 6, 2012, Pages 824-830

  Deorah, Sundeep ^a   Rao, Marepalli B ^a   Raman, Rachna ^a   Gaitonde, Krishnanath ^a,b   Donovan, James F ^a,b  

^a UNIVERSITY OF CINCINNATI   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

prostate; SEER; small cell carcinoma; survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; METASTASIS POTENTIAL; POPULATION RESEARCH; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SMALL CELL CARCINOMA; SURVIVAL PREDICTION; SURVIVAL RATE; SURVIVAL TIME;

ADENOCARCINOMA; AGED; CARCINOMA, SMALL CELL; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS; RISK FACTORS; SEER PROGRAM; SURVIVAL RATE; TREATMENT OUTCOME; UNITED STATES;

EID: 84857657168     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10523.x     Document Type: Article

References (22)

1. Wenk RE, Bhagavan BS, Levy R, Miller D, Weisburger W,. Ectopic ACTH, prostatic oat cell carcinoma, and marked hypernatremia. Cancer 1977; 40: 773-8 (Pubitemid 8177897)
2. Sandhu SS, Denton A, Jarmulowicz M, Pigott K, Kaisary AV,. Pure small cell carcinoma of the prostate. Clin Oncol (R Coll Radiol) 1997; 9: 412-14 (Pubitemid 28017848)
3. Kaplan M, Atakan IH, Bilgi S, Inci O,. Case report: subcutaneous metastasis from small cell carcinoma of the prostate. Int Urol Nephrol 2007; 39: 157-60 (Pubitemid 46722959)
4. Yashi M, Terauchi F, Nukui A, et al,. Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review. Urol Oncol 2006; 24: 313-17 (Pubitemid 43963405)
5. Oesterling JE, Hauzeur CG, Farrow GM,. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. J Urol 1992; 147: 804-7
6. Spiess PE, Pettaway CA, Vakar-Lopez F, et al,. Treatment outcomes of small cell carcinoma of the prostate: a single-center study. Cancer 2007; 110: 1729-37 (Pubitemid 47557297)
7. Surveillance, Epidemiology, and End Results (SEER) website. Overview of the SEER program. Available at:. Accessed 1 August 2011
8. Surveillance, Epidemiology, and End Results (SEER) website. Quality improvement tools. Available at:. Accessed 27 September 2008
9. Têtu B, Ro JY, Ayala AG, Johnson DE, Logothetis CJ, Ordonez NG,. Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer 1987; 59: 1803-9 (Pubitemid 17075428)
10. Abbas F, Civantos F, Benedetto P, Soloway MS,. Small cell carcinoma of the bladder and prostate. Urology 1995; 46: 617-30
11. Mackey JR, Au HJ, Hugh J, Venner P,. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J Urol 1998; 159: 1624-9 (Pubitemid 29117354)
12. Anker CJ, Dechet C, Isaac JC, Akerley W, Shrieve DC,. Small-cell carcinoma of the prostate. J Clin Oncol 2008; 26: 1168-71
13. Wang W, Epstein JI,. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Am J Surg Pathol 2008; 32: 65-71
14. Govindan R, Page N, Morgensztern D, et al,. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the Surveillance, Epidemiologic, and End Results database. J Clin Oncol 2006; 24: 4539-44 (Pubitemid 46630948)
15. Lally BE, Geiger AM, Urbanic JJ, et al,. Trends in the outcomes for patients with limited stage small cell lung cancer: an analysis of the Surveillance, Epidemiology, and End Results database. Lung Cancer 2009; 64: 226-31
16. Psyrri A, Murren J,. Small cell lung cancer: strategies to optimize chemotherapy response. Cancer J 2001; 7 (Suppl. 1): S28-34
17. Siefker-Radtke AO, Kamat AM, Grossman HB, et al,. Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer. J Clin Oncol 2009; 27: 2592-7
18. Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF,. Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population. Med Care 2002; 40: IV-3-18
19. Cooper GS, Virnig B, Klabunde CN, Schussler N, Freeman J, Warren JL,. Use of SEER-Medicare data for measuring cancer surgery. Med Care 2002; 40: IV-43-8
20. Chow WH, Devesa SS,. Underreporting and misclassification of urinary tract cancer cases on death certificates. Epidemiology 1996; 7: 517-20 (Pubitemid 26277698)
21. Amato RJ, Logothetis CJ, Hallinan R, Ro JY, Sella A, Dexeus FH,. Chemotherapy for small cell carcinoma of prostatic origin. J Urol 1992; 147: 935-7
22. Papandreou CN, Daliani DD, Thall PF, et al,. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 2002; 20: 3072-80 (Pubitemid 34791096)